Sealed Air Corporation (NYSE:SEE) announced that it has commenced a cash tender offer to purchase any and all of the outstanding $750 million in aggregate principal amount of 8.125% Senior Notes due 2019 of the co, on the terms and subject to the conditions set forth in the Offer to Purchase and Consent Solicitation Statement, dated the date hereof, and in the related Letter of Transmittal and Consent. Sealed Air Corporation (NYSE:SEE) belongs to Consumer Goods sector. Its net profit margin is 5.00% and weekly performance is 3.39%. On last trading day company shares ended up $38.12. Sealed Air Corporation (NYSE:SEE) distance from 50-day simple moving average (SMA50) is 8.82%. Yahoo! Inc. (NASDAQ:YHOO) is buying digital video advertising service BrightRoll for $640 million (Dh2,350 million) in the internet company’s latest attempt to boost its revenue after years filled mostly with financial futility. Yahoo! Inc. (NASDAQ:YHOO) shares fell -0.73% in last trading session and ended the day at $49.05. YHOO Gross Margin is 71.90% and its return on assets is 28.80%. Yahoo! Inc. (NASDAQ:YHOO) quarterly performance is 35.53%. Hudson City Bancorp (NASDAQ:HCBK) last announced its earnings results on Wednesday, October 22nd. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.01. During the same quarter in the previous year, the company posted $0.09 earnings per share. On average, analysts predict that Hudson City Bancorp will post $0.28 earnings per share for the current fiscal year. On 11 November, Hudson City Bancorp, Inc. (NASDAQ:HCBK) shares moved up 1.03% and was closed at $9.85. HCBK EPS growth in last 5 year was -16.30%. Hudson City Bancorp, Inc. (NASDAQ:HCBK) year to date (YTD) performance is 6.26%. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free aldehydes, today announced its financial results for the third quarter and nine months ended September 30, 2014. Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, commented, "We continued to execute our business strategy during the third quarter, and, by year end, we expect to file Investigational Drug Applications for clinical testing of our lead product candidate, NS2, for the treatment of Sjögren-Larsson Syndrome and acute anterior uveitis. Accordingly, we remain on track with the initiation of our clinical trials in the near term, with data expected in 2015." Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) ended the last trading day at $7.51. Company weekly volatility is calculated as 11.34% and price to cash ratio as 3.63. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) showed a weekly performance of -4.82%. Quantum Corp (NYSE:QTM) SVP Janae S. Lee sold 170,000 shares of Quantum Corp stock on the open market in a transaction that occurred on Thursday, November 6th. The shares were sold at an average price of $1.40, for a total transaction of $238,000.00. Following the transaction, the senior vice president now directly owns 517,651 shares in the company, valued at approximately $724,711. Quantum Corporation (NYSE:QTM) shares fell -0.68% in last trading session and ended the day at $1.45. QTM Gross Margin is 43.10% and its return on assets is -6.90%. Quantum Corporation (NYSE:QTM) quarterly performance is 16.00%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
